Related Experiment Video
Updated: Feb 27, 2026

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
Published on: July 17, 2014
Uptake and metabolism of arginine impact Plasmodium development in the liver
Patrícia Meireles1, António M Mendes1, Rita I Aroeira1,2
1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Abstract:
Prior to infecting erythrocytes and causing malaria symptoms, Plasmodium parasites undergo an obligatory phase of invasion and extensive replication inside their mammalian host's liver cells that depends on the parasite's ability to obtain the nutrients it requires for its intra-hepatic growth and multiplication. Here, we show that L-arginine (Arg) uptake through the host cell's SLC7A2-encoded transporters is essential for the parasite's development and maturation in the liver. Our data suggest that the Arg that is taken up is primarily metabolized by the arginase pathway to produce the polyamines required for Plasmodium growth. Although the parasite may hijack the host's biosynthesis pathway, it relies mainly upon its own arginase-AdoMetDC/ODC pathway to acquire the polyamines it needs to develop. These results identify for the first time a pivotal role for Arg-dependent polyamine production during Plasmodium's hepatic development and pave the way to the exploitation of strategies to impact liver infection by the malaria parasite through the modulation of Arg uptake and polyamine synthesis.
Insights
L-arginine uptake via host SLC7A2 transporters fuels Plasmodium parasite growth in the liver. This nutrient fuels polyamine production, crucial for parasite development and a potential target for malaria control.
Area of Science:
- Parasitology
- Molecular Biology
- Malaria Research
Background:
- Plasmodium parasites infect the liver before causing malaria symptoms.
- Intrahepatic parasite development requires nutrient acquisition for growth and multiplication.
- Understanding nutrient dependency is key to targeting early-stage malaria infection.
Purpose of the Study:
- To investigate the role of L-arginine (Arg) uptake in Plasmodium intrahepatic development.
- To elucidate the metabolic pathways utilized by the parasite for nutrient utilization in the liver.
- To identify potential therapeutic targets for blocking liver-stage malaria infection.
Main Methods:
- Analysis of L-arginine uptake in host liver cells infected with Plasmodium parasites.
- Investigating the function of SLC7A2 transporters in parasite nutrient acquisition.
- Metabolic profiling to identify pathways involved in polyamine synthesis from L-arginine.
Main Results:
- L-arginine uptake through host SLC7A2 transporters is essential for Plasmodium liver-stage development.
- Metabolism of L-arginine via the arginase pathway produces polyamines critical for parasite growth.
- Plasmodium parasites primarily utilize their own arginase-AdoMetDC/ODC pathway for polyamine synthesis.
Conclusions:
- L-arginine-dependent polyamine production is pivotal for Plasmodium hepatic development.
- Targeting L-arginine uptake and polyamine synthesis pathways offers a novel strategy against liver-stage malaria.
- This study identifies a critical nutrient dependency for blocking malaria transmission.
More Related Videos
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
10:22Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...